Download PDF
1 / Pages

Other users also viewed these articles

Comparison of disease activity in patients with ankylosing spondylitis under TNFi or NSAID treatment, is there any difference? An observational study Mireia Moreno; Marta Arévalo; Marc Zamora; Caridad Pontes; Juan Carlos Oliva; Jordi Gratacós;
Reumatol Clin. 2021;17:192-6
Implementation of the recommendations for the psychological management of patients with spondyloarthritis and inflammatory bowel disease Ana Urruticoechea-Arana; Jesús Sanz; Daniel Ginard; Yago González-Lama; Xavier Juanola; Miriam Almirall; Natalia Borruel; Jordi Gratacós; Estíbaliz Loza;
Reumatol Clin. 2023;19:423-9
Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study Josefina Cortés-Hernández; Carlos Marras Fernández-Cid; Jose Luis Andreu Sánchez; Jaime Calvo Alén; Angel M. García-Aparicio; Elvira Díez Álvarez; Francisco Javier Hidalgo Bermejo; Carlos Coronell; Alessandra Perna; Josep Ordi Ros;
Reumatol Clin. 2023;19:312-8